191 related articles for article (PubMed ID: 25881717)
21. Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.
Hafkin J; Modongo C; Newcomb C; Lowenthal E; MacGregor RR; Steenhoff AP; Friedman H; Bisson GP
Int J Tuberc Lung Dis; 2013 Mar; 17(3):348-53. PubMed ID: 23321297
[TBL] [Abstract][Full Text] [Related]
22. Anti-tuberculosis drug resistance in new and previously treated pulmonary tuberculosis cases in Burkina Faso.
Sangaré L; Diandé S; Badoum G; Dingtoumda B; Traoré AS
Int J Tuberc Lung Dis; 2010 Nov; 14(11):1424-9. PubMed ID: 20937182
[TBL] [Abstract][Full Text] [Related]
23. Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009.
van Altena R; de Vries G; Haar CH; de Lange WC; Magis-Escurra C; van den Hof S; van Soolingen D; Boeree MJ; van der Werf TS
Int J Tuberc Lung Dis; 2015 Apr; 19(4):406-12. PubMed ID: 25859995
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of rifampicin resistance tuberculosis among HIV/TB coinfected patients in Benue State, Nigeria.
Ejeh FE; Undiandeye A; Okon K; Moshood KH
Pan Afr Med J; 2021; 38():203. PubMed ID: 33995809
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of rifampicin-resistant Mycobacterium tuberculosis among human-immunodeficiency-virus-seropositive patients and their treatment outcomes.
Vidyaraj CK; Chitra A; Smita S; Muthuraj M; Govindarajan S; Usharani B; Anbazhagi S
J Epidemiol Glob Health; 2017 Dec; 7(4):289-294. PubMed ID: 29110871
[TBL] [Abstract][Full Text] [Related]
26. Ethnic Disparities for Gynecologic Cancers in Israel.
Kadan Y; Fishman A; Helpman L
J Racial Ethn Health Disparities; 2020 Jun; 7(3):421-427. PubMed ID: 31768965
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and associated risk factors of drug-resistant tuberculosis in Thailand: results from the fifth national anti-tuberculosis drug resistance survey.
Kamolwat P; Nateniyom S; Chaiprasert A; Disratthakit A; Mahasirimongkol S; Yamada N; Smithtikarn S
Trop Med Int Health; 2021 Jan; 26(1):45-53. PubMed ID: 32997863
[TBL] [Abstract][Full Text] [Related]
28. Pilot study on multidrug resistant tuberculosis in Nigeria.
Lawson L; Habib AG; Okobi MI; Idiong D; Olajide I; Emenyonu N; Onuoha N; Cuevas LE; Ogiri SO
Ann Afr Med; 2010; 9(3):184-7. PubMed ID: 20710112
[TBL] [Abstract][Full Text] [Related]
29. Determinants of the Sympatric Host-Pathogen Relationship in Tuberculosis.
David S; Mateus AR; Duarte EL; Albuquerque J; Portugal C; Sancho L; Lavinha J; Gonçalves G
PLoS One; 2015; 10(11):e0140625. PubMed ID: 26529092
[TBL] [Abstract][Full Text] [Related]
30. The fourth national anti-tuberculosis drug resistance survey in Viet Nam.
Nhung NV; Hoa NB; Sy DN; Hennig CM; Dean AS
Int J Tuberc Lung Dis; 2015 Jun; 19(6):670-5. PubMed ID: 25946357
[TBL] [Abstract][Full Text] [Related]
31. Why not the best? Social anxiety symptoms and perfectionism among Israeli Jews and Arabs: a comparative Study.
Iancu I; Bodner E; Joubran S; Ben Zion I; Ram E
Compr Psychiatry; 2015 May; 59():33-44. PubMed ID: 25691264
[TBL] [Abstract][Full Text] [Related]
32. Multidrug-resistant Mycobacterium tuberculosis: a report of cosmopolitan microbial migration and an analysis of best management practices.
Joean O; Thiele T; Schütz K; Schwerk N; Sedlacek L; Kalsdorf B; Baumann U; Stoll M
BMC Infect Dis; 2020 Sep; 20(1):678. PubMed ID: 32942990
[TBL] [Abstract][Full Text] [Related]
33. Genetic diversity of multidrug-resistant Mycobacterium tuberculosis strains isolated from tuberculosis patients in Iran using MIRU-VNTR technique.
Khosravi AD; Shahraki AH; Dezfuli SK; Hashemzadeh M; Goodarzi H; Mohajeri P
Kaohsiung J Med Sci; 2017 Nov; 33(11):550-557. PubMed ID: 29050672
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology and control of tuberculosis in Victoria, a low-burden state in south-eastern Australia, 2005-2010.
Lavender CJ; Globan M; Kelly H; Brown LK; Sievers A; Fyfe JA; Lauer T; Leslie DE
Int J Tuberc Lung Dis; 2013 Jun; 17(6):752-8. PubMed ID: 23676157
[TBL] [Abstract][Full Text] [Related]
35. Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis.
Park S; Jo KW; Lee SD; Kim WS; Shim TS
Respir Med; 2017 Oct; 131():43-48. PubMed ID: 28947041
[TBL] [Abstract][Full Text] [Related]
36. Tuberculosis among foreign-born persons, Singapore, 2000-2009.
Kyi Win KM; Chee CB; Shen L; Wang YT; Cutte J
Emerg Infect Dis; 2011 Mar; 17(3):517-9. PubMed ID: 21392448
[TBL] [Abstract][Full Text] [Related]
37. Drug-resistant TB prevalence study in 5 health institutions in Haiti.
Hoffmann J; Chedid C; Ocheretina O; Masetti C; Joseph P; Mabou MM; Mathon JE; Francois EM; Gebelin J; Babin FX; Raskine L; Pape JW
PLoS One; 2021; 16(3):e0248707. PubMed ID: 33735224
[TBL] [Abstract][Full Text] [Related]
38. Use of genotyping based clustering to quantify recent tuberculosis transmission in Guadeloupe during a seven years period: analysis of risk factors and access to health care.
Ferdinand S; Millet J; Accipe A; Cassadou S; Chaud P; Levy M; Théodore M; Rastogi N
BMC Infect Dis; 2013 Aug; 13():364. PubMed ID: 23914829
[TBL] [Abstract][Full Text] [Related]
39. Tuberculosis in children treated with second-line drugs under programmatic conditions in Lima, Peru.
Villarreal J; Alarcón V; Alarcón-Arrascue E; Moore DAJ; Heldal E; Mendoza-Ticona A
Int J Tuberc Lung Dis; 2018 Nov; 22(11):1307-1313. PubMed ID: 30355410
[TBL] [Abstract][Full Text] [Related]
40.
Mai TQ; Martinez E; Menon R; Van Anh NT; Hien NT; Marais BJ; Sintchenko V
Am J Trop Med Hyg; 2018 Dec; 99(6):1397-1406. PubMed ID: 30382014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
